Monica Shandal (she/her)
@monicashandal
Economics PhD Candidate UCSC 🇺🇸 | REES Ualberta 🇨🇦 | Let's talk about TB
ID: 1136139232206999552
05-06-2019 05:14:36
124 Tweet
269 Takipçi
675 Takip Edilen
Thank you for joining in our webinar, and supporting our call to implement National TB Elimination Strategy. 👏A special thanks to our expert speakers Dr.Dick Menzies and Dr. Christina Greenway, Monica Shandal (she/her), Dr. Elizabeth Rea, Adam R Houston, and Dr. Courtney Heffernan!
In just 22 hours, 578,000 people have watched this video about Johnson & Johnson's pursuit of secondary patents for bedaquiline and how this will lead to millions being unable to receive curative treatment for tuberculosis. youtu.be/tMhgw5SW0h4 #PatientsNotPatents Johnson & Johnson
"Because of Johnson & Johnson's secondary patent, 56% of the global market will not have access to generic bedaquiline until 2027" ... A key drug in drug resistant TB treatment. More can be found in this open letter to J&J treatmentactiongroup.org/wp-content/upl…
Check out this piece I worked on with Ekatha Ann and Results Canada! In 2023 #TB continues to infect millions around the world!
Many TB medicines are not marketed in Canada. Accessing these drugs requires complex regulatory pathways that lead to delays. People in Canada deserve timely access to new TB regimens that are available around in world. Read Stop TB Canada’s report: bit.ly/accesstoTBmeds
Shortages of essential TB medicines & inconsistent notification mechanisms are complicating treatment delivery & continuity of care in Canada. Efforts should be taken to ensure a stable supply of TB medicines. Read Stop TB Canada’s report: bit.ly/accesstoTBmeds